Hims & Hers officer plans sale of 7,954 shares

Officer Mohamed Elshenawy files a Rule 144 notice covering 7,954 Hims & Hers Class A shares from restricted stock vesting, plus discloses a June 2026 sale of 30,040 shares.

Available on EDGAR 09/15/2026 - 10:22 AM EDT Accepted by SEC EDGAR 09/15/2026 - 10:22 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) has a notice of proposed sale under Rule 144 filed for the account of officer Mohamed Elshenawy. The notice covers the potential sale of 7,954 Class A shares, arising from restricted stock vesting on August 15, 2026, held at Fidelity Brokerage Services LLC.

The filing also reports that Mohamed Elshenawy previously sold 30,040 Class A shares on June 17, 2026 for $946,260.00. Fidelity Brokerage Services LLC signed the notice as attorney-in-fact for Mohamed Elshenawy.

Key Figures

Shares proposed for sale: 7,954 Class A shares Shares sold in prior transaction: 30,040 Class A shares Proceeds from prior sale: $946,260.00 +3 more

6 metrics

Shares proposed for sale 7,954 Class A shares Potential Rule 144 sale from restricted stock vesting on August 15, 2026

Shares sold in prior transaction 30,040 Class A shares Sale reported for June 17, 2026

Proceeds from prior sale $946,260.00 Aggregate sale price for 30,040 shares on June 17, 2026

Market value reference $225,814.06 Value associated with the 7,954 shares in the securities information section

Vesting date August 15, 2026 Date of restricted stock vesting for the 7,954 shares

Past sale date June 17, 2026 Date of sale of 30,040 shares

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact, compensation

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Class A | 08/15/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"attorney-in-fact for Mohamed Elshenawy"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

compensation financial

"08/15/2026 | Compensation"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for HIMS?

The filing discloses a Rule 144 notice for officer Mohamed Elshenawy covering the potential sale of 7,954 Class A shares of Hims & Hers Health, Inc., arising from restricted stock vesting on August 15, 2026.

How many HIMS shares are proposed to be sold under this Form 144?

The notice covers a proposed sale of up to 7,954 Class A shares of Hims & Hers Health, Inc., tied to restricted stock vesting on August 15, 2026 and classified as compensation.

What prior HIMS share sales by Mohamed Elshenawy are reported?

The filing reports that 30,040 Class A shares were sold on June 17, 2026 for total proceeds of $946,260.00. This is disclosed in the section covering securities sold during the past three months.

Who is the broker and how is the Form 144 signed for HIMS?

The shares are held at Fidelity Brokerage Services LLC. The notice is signed “/s/ Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Mohamed Elshenawy.”

What type of HIMS security is involved in this Form 144?

The securities involved are Class A shares of Hims & Hers Health, Inc. The Form 144 identifies the transaction as related to Restricted Stock Vesting and categorized as Compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002068597
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hims & Hers Health, Inc.
SEC File Number	001-38986
Address of Issuer	2269 CHESTNUT ST #523 SAN FRANCISCO CALIFORNIA 94123
Phone	415-851-0195
Name of Person for Whose Account the Securities are To Be Sold	Elshenawy Mohamed
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7954	225814.06	224935790	09/15/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	08/15/2026	Restricted Stock Vesting	Issuer			7954	08/15/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mohamed Elshenawy 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/17/2026	30040	946260.00

144: Remarks and Signature

Remarks
Date of Notice	09/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/01/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Mohamed Elshenawy
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)